Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00456560
Status:
COMPLETED
Last Update Posted:
2007-09-17
First Post:
2007-04-03
Brief Title:
AV650 Drug-Drug Interaction Study
Sponsor:
Avigen
Organization:
Avigen
Study Overview
Official Title:
A Phase I Randomized Two-Period Single-Center Study to Assess the Effect of CYP2D6 and CYP2C19 Inhibitors on a Single Oral Dose of AV650 300 mg in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2007-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effects that paroxetine and fluvoxamine have on the way the body distributes breakdowns and eliminates AV650 In addition information about any side effects that may occur will also be collected
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None